1Suzuki K,Murakami K,Tomita T,et al.A case of young adult presenting with cerebral infarction caused by homocystinuria[J].No To Shinkei,2004;56(9):781-4.
2Minuz P,Patrignani P,Gaino S,et al.Determinants of platelet activation in human essential hypertension[J].Hypertension,2004;43(1):64-70.
4Collins R,Peto R,Macmahon S,et al.Blood,pressure,stroke,and coronary heart disease.Part 2.Short-term reductions in blood pressure:overview of randomized drug trials in their epidemiological context[J].Lancet,1990;335(8693):827-38.
5Angiolillo DJ,Fernandez-Ortiz A,Bernardo E,et al.Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment[J].Diabetes,2005;54(8):2430-5.
7Coma-canella I,Velasc A.Variability in individual responsiveness to aspirin:clinical implications and treatment[J].Cardiovasc Hematol Disord Drug Targets,2007;7(4):274-87.
4[2]De La Cruz JP,Gonzalez-Correa JA,Guerrero A.Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers[J].2003,17:363-372.
5Buchanan MR, Brister SJ. Individual variation in the effect of ASA on platelet function:Implications for the use of ASA clinically. Can J cardiol,1995,11:221-227.
6Eikelbocm JW, Hirsh J, White JI, et al. Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovacsular death in patients at risk of high for cardiovascular event. Circulation, 2002, i05 : 1650-1655.
7Pearson TA, Mensah GA, Alexander RW,et al. Markers of inflammation and cardiovascular disease, application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association.Circulation ,2003,107:499-512.
5Carrera E, Maeder - Ingvar M, RossettiAO,et al. Trends in risk factors, patterns and causes in hospitalized strokes over 25 years: The Lausanne Stroke Registry [J]. Cerebrovasc Dis, 2007, 24(1): 97-103.
6Valachovicova T, Slivova V, Bergman H, et al. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF - kappaB/AP - 1 - dependent and - independent pathways [ J ]. Int J Oncol, 2004, 25(5) : 1389 - 1395.
7Born GVRO. Aggregation of blood platelets by adenosine diphosphate and its reversal[ J]. Nature, 1962, 194(6) :927 -929.
